PTAB statistics

PTAB Trial Statistics as of February 28, 2017

As of February 28, 2017, USPTO records show 6,526 AIA trial petitions filed since September 16, 2012 (5,956 IPR, 506 CBM, 48 PGR, 16 derivation). The Board had instituted trial on 3,132 petitions and denied 2,074 (60.2% instituted) and had issued 1,687 final written decisions. In fiscal year 2017 to that date, 856 petitions were filed.

Key Facts

As of
February 28, 2017
Fiscal year
FY2017
Petitions filed (cumulative)
6,526
Institution rate (cumulative)
60.2%
Petitions filed (FY2017 to date)
856
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of February 28, 2017
  2. Fiscal Year 2017 to Date
  3. Change Since January 31, 2017
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of February 28, 2017, which falls in fiscal year 2017 (October 1, 2016 to September 30, 2017). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2017 statistics page.

Cumulative Figures as of February 28, 2017

Events from September 16, 2012 to February 28, 2017, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed5,95648506166,526
Institution decisions: instituted2,8411727403,132
Institution decisions: denied1,8741418242,074
Institution rate (by petition)60.3%54.8%60.1%0.0%60.2%
Final written decisions1,514916401,687
Terminations without a final written decisionCount
Settlements897
Adverse judgment0
Dismissed1
Other terminations166

Fiscal Year 2017 to Date

Events from October 1, 2016 to February 28, 2017:

MeasureIPRPGRCBMDERTotal
Petitions filed81311302856
Institution decisions: instituted3223110336
Institution decisions: denied1845141204
Institution rate (by petition)63.6%37.5%44.0%0.0%62.2%
Final written decisions2636120281
Terminations without a final written decisionCount
Settlements198
Settled before institution106
Settled after institution92
Adverse judgment0
Dismissed1
Other terminations65

Change Since January 31, 2017

Between the previous dated page (January 31, 2017) and February 28, 2017, 130 petitions were filed, 89 trials were instituted, 43 petitions were denied institution and 39 final written decisions issued. The cumulative institution rate moved from 60.0% to 60.2%.

Trial Types Covered

5,956 of the 6,526 petitions (91.3%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (506), post-grant review under chapter 32 (48) and derivation proceedings (16). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before February 28, 2017: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of February 28, 2017?

USPTO records show 6,526 petitions filed from September 16, 2012 to February 28, 2017: 5,956 IPR, 506 CBM, 48 PGR and 16 derivation.

What was the PTAB institution rate as of February 28, 2017?

Cumulatively, 60.2% by petition: 3,132 instituted and 2,074 denied. In FY2017 to that date the rate was 62.2%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.